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Several lines of evidence suggest that the mechanism ofT cell recognition of an-
tigen is similar in both class I and class II MHC-restricted systems . First, theTCR
molecules that recognize antigen in the context of either the class I or class IIMHC
molecules are assembled from the same set of germline variable region genes (V,-
j, and V#-Dfjfl) (1). Furthermore, several groups have demonstrated that the same
V region gene can be used by different T cell clones that haveMHC restriction to
different classes, either class I or II (2-5) . Second, both the class I and II MHC
moleculeshave functional and structural similarities . Guillet et al . (6) demonstrated
that class II MHC molecules have a single antigen binding site based on functional
analysis of antigen competition . The crystal structure ofa class I (HLA-A2) mole-
cule also suggests a single antigen binding site that is a cleft between two a helices
located at the NH2 terminus of the molecule (7) . In addition, a model of the class
II (I-A') structure proposes tertiary structural homology with the class I molecule,
including a single antigen binding site (8) . Thus, although the class I and IIMHC
molecules are different proteins and have primary sequence variability, the tertiary
structureofboth the class I and II molecules is predicted to be similar. Third, short
synthetic peptides encompassing immunodominant regionsofaprotein can replace
protein antigen in both class I and II-restricted T cell responses . Class I-restricted
Tcells lyse histocompatible target cells incubated with the appropriate peptide (9-14),
and class II-restricted T cells proliferate and secrete lymphokines in response to
histocompatibleAPCs plus peptide (15-18) . Furthermore, two groups using different
methods analyzed immunogenic peptides and identified structural motifs common
to both class I and II-restricted peptides (14, 19). Thus, the trimolecular interac-
tions between TCR, MHC molecule, and antigen have many similarities between
the class I and class II systems .
Materials and Methods
Mice.
￿
6-10-wk-old mice oftheCBA, BALB/c, C57/B6, A/J, B10.A,B10.A(2R), B10.A(4R),
B10.A(5R), and A.TL strains were purchased from TheJackson Laboratory (Bar Harbor,
ME) . B10.GDmice were a gift of Dr. Don Schrefller (Washington University, St . Louis, MO).
All mice were maintained in microisolator cages .
Peptides.
￿
All peptides were synthesized by the solid phase method of Merrifield usingan
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automated peptide synthesizer (No. 430A; Applied Biosystems,) as previously described (20).
Peptides were desalated on a G-25 column (2.5 x 90 cm) equilibrated with 4 M glacial acetic
acid and then lyophilized twice after resuspension in distilled water. The purity of all peptides
was determined by amino acid analysis.
Viruses.
￿
Influenza virus strains A/NT/60/68 and A/Jap/57 were grown in the allantoic
cavity of 10-d-old embryonated chicken eggs and stored as infectious allantoic fluid (21).
Lymph Node Proliferation.
￿
Mice were immunized subcutaneously with 50,ug of the appro-
priate peptide in CFA and 7-10 d later popliteal, inguinal, and pararotic lymph nodes were
removed. Lymph node cells from three mice of each strain were pooled and then split into
six equal aliquots, which were incubated with the appropriate mAb for 1 h on ice, washed,
and incubated with rabbit complement (Pet-Freeze Biologicals, Rogers, AR) at 1 :10 plus
mouse anti-rat K (MAR18.5) (22). Cytotoxicity index based on trypan blue dye exclusion
ofa typical experiment was: no mAb, 5% ; anti-CD4 (GK1.5, reference 29), 35%; anti-CD8,
(AD4, reference 30), 24%; antiThy-1 (13 .4, reference 31), 64%; anti-ARS (45-112, reference
32), 6% ; complement control, 7 0 /c. All mAbs were prepared as ascites and used at 1 :100 dilu-
tion. 6 x 105 lymph node cells plus 2 x 105 irradiated syngeneic splenic APCs cells were
cultured in 100 td in one-half area wells in microtiter plates with the indicated concentration
of peptide for 48 h. 8 h before harvesting 1 uCi per well of [3H]thymidine was added. Cells
were harvested with an automated cell harvester (Skatron Inc.) and [3H]TdR incorporation
was measured by scintillation counting.
TCell Hybridomas.
￿
Hybridomas were prepared as previously described (23). Briefly, mice
were immunized subcutaneously with 50 jig peptide in CFA and 7-10 d later cells from draining
lymph nodes were purified and cultured at 4 x 106/ml with 10 ug/ml peptide for 2 d. Viable
cells were purified by Ficoll-Metriozate gradient centrifugation and fused with an equal number
of BW5147 cells using 0.5 ml 50% polyethylene glycol 1500 in RPMI. Hybridomas were
assayed for antigen-specific reactivity by analysis of IL-2 secretion. 5 x 104 hybridomas plus
5 x 104 APCs plus 10 btg/ml of peptide were cultured for 24 h in microtiter plates. 50 P1
of supernatant was added to 104 of the IL-2-dependent cell line CTLL.2 cells for 20 h, then
1 ltCi [;H]TdR per well was added per well for 4 h. Cells were harvested with an automated
cell harvester and thymidine incorporation was measured by scintillation counting (23).
Cytotoxicity Assay.
￿
Mice were immunized intranasally with 10 hemaglutinin units (HAU)'
of influenza A virus and 2-4 wks later spleen cells were harvested and cultured at 106/ml
with 2 x 105 virus-infected syngeneic spleen cells previously irradiated in a cesium irradi-
ator (2,000 rad). After 5 d cells were harvested and purified in Ficoll-Metrizoate. The effector
cells were added to target cells incubated in 0.5 mCi of "Cr plus 100 HAU influenza virus
when indicated for 2 h and washed four times. 2 x 104 target cells were added per well in
U-bottomed microtiter plates. Target cells were El-4 (H-26), P815 (H-2d), and BW5147 (H-
2k). After a 4-h incubation period supernatants were harvested with a supernatant collec-
tion system (Skatron, Inc.) and counted with a gamma counter (Pakcard Instruments, Specific
Cr release was calculated as: Specific Cr release = (experimental - spontaneous counts)/(to-
tal - spontaneous counts).
Results
Our experiments test the hypothesis that class I and II-restricted peptides are
functionally interchangeable, based on the assumption that immunogenic peptides
have similar structural motifs. Mice ofthree different H-2 haplotypes were immunized
with a peptide from influenza nucleoprotein composed of residues 365-80 (NP365-
80), which was identified previously in a class I-restricted cytotoxic response (9).
Lymph node cells from immunized mice were assayed for T cell proliferation. A/J,
B10 .A, and B10 .A(4R) mice demonstrated a positive proliferative response; how-
ever, C57/B6, BALB/c, and B10.A(5R) were negative (Table I) . Townsend et al. had
' Abbreviation used in this paper: HAU, hemagglutinin units.PERKINS ET AL.
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TABLE I
NP365-80 Lymph Node Proliferation
4 x 105 lymph node cells were incubated with NP365-80 or control peptide at
concentrations from 100 to 0.03 AM for 48 h. 1 WCi of [3H]TdR per well was
added for the last 8 h of culture, and cells were harvested with an automated
cell harvester, and thymidine incorporation was measured by sciontillation count-
ing. Stimulation index (positive cpm/background cpm) was greater than seven
for all positive responses.
previously shown that NP365-80 is class I Db restricted (9). In our experiments the
C57/B6 strain that expresses D6 did not demonstrate a proliferative response,
whereas the A/J and B10.A strains that express the H-2 Dd and Dk alleles, respec-
tively, were positive. These results suggest that the proliferating cells were not class
I restricted. The three responding strains A/J, B10.A, andB10.A(4R) (butnotC57/B6
or BALB/c) only share the class II I-Ak allele further suggesting that the prolifera-
tive T cell response to NP365-80 is class II restricted.
To test the generality of this result, we synthesized four additional murine class
I-restricted peptides including two peptides from influenza nucleoprotein (NP50-
63 [9] and NP147-158 [8]) and two peptides from influenzahemagglutinin (HA202-
21 and HA523-45 [13]), immunized three strains ofmice, and subsequently assayed
lymph node proliferative responses. In this experiment specific Tcell subsets were
killed with complementplus mAbsthat recognize theCD4, CD8, orThy-1 to deter-
mine which T cell subset was proliferating. In Fig. 1, a-e, CD4+ but not CD8+ T
cells proliferated in response toallfive different peptides NP50-63, NP147-58, NP365-
80, HA202-21, HA523-45 defined previouslyinclass I-restrictedcytotoxicity assays.
Mice of all three haplotypes (H-2b,d,k) responded to HA202-21 ; however, for the
other four peptides onlyone ofthe three haplotypes demonstrated apositive response
(datafrom nonresponding haplotypes not shown). The failure to respond to a specific
peptide by the majority ofH-2 haplotypes demonstrates the specificity ofthe T cell
responses. Because CD4+ T cells are class II restricted, these results provided fur-
ther evidence that the previously defined class I-restricted peptides also generated
a class II-restricted T cell response. Concordant resultswere obtained when lymph
node cells were analyzed for IL-2 secretion (not shown).
To further demonstrate theclass II MHC restriction ofthe proliferative responses,
T cell hybridomas were made from mice immunized with NP365-80 and screened
for IL-2 secretion after culture with peptide plus fibroblast L cells transfected with
either I-A' or I-Ek as APCs (gifts of R. Germain, National Institutes of Health,
Bethesda, MD). Of 169 hybrids specific for NP365-80 derived from two separate
fusions in A/J and B10.A mice, 162 were I-A' restricted. Seven I-E'-restricted
hybrids were also identified (Table II). Thus, CD4+ class II-restricted T cells can
Strain
H-2
KAED
Response
NP365-80
C57/B6 bbbb -
BALB/c dddd -
B10.A kkkk +
A/J kkkd +
B10.A(4R) kkbb +
B10.A(5R) bbkd -282
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FIGURE 1 .
￿
Lymph node proliferation analysis of peptides previously identified in murine class
I-restricted cytotoxicity assays . Peptides (a) NP50-63 (11), (b) NP147-58 (12), (c) NP365-80 (9),
(d) HA202-21 (13) (e) HA523-45 (13) were synthesized by the solid phase method of Merrifield
using an automated peptide synthesizer (No. 430A ; Applied Biosystems) (20) . Six aliquots of
lymph node cells from each strain were assayed: no peptide and no mAb or complement (C')
(O), cI73-88 (peptide 73-88 from X repressor cI) with no mAb or C'(41), peptide andno mAb
or C' (0), peptide plus anti-CD4 mAb (GK1.5) (29) plus C' ("), peptide plus anti-CD8 mAb
(AD4, reference 30) plus C' (p), peptide plus antiThy-1 mAb (13.4, reference 31) plus C' (/),
peptide plus antiarsonate (ARS)mAb (45-112, reference 32) plus C' (V), peptide plus C' without
mAb (") . Mouse strains were CBA (a, c, and e), BALB/c (b), and C57/136 (d).
respond to NP365-80, a peptide previously identified as class I Db-restricted pep-
tide, in the context of the class II I-A' molecule, confirming that the same peptide
was recognized in both a class I and class II-restricted manner.
Next we tested the same five peptides in cytotoxicity assays to confirm their classPERKINS ET AL.
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TABLE II
NP365-80-specific T Cell Hyóridomas
Mice were immunized subcutaneously with 50feg of NP365-80 in CFA and 7-10
d later draining lymph nodes were removed and cells were stimulated with 10
;tg/ml NP365-80 at 4 x 106 cells/ml for 48 h. Cells were then purified with Ficoll-
Metrizoate centrifugation and fused with BW5147 using PEG 1500 as previous-
ly described (23). 5 x 104 hybridoma cells plus 5 x 104 APCs were incubated
with 10 jig/ml NP365-80 for 24 h. 50 Al supernatant was harvested and added
to 104 CTLL.2 IL2-dependent cells for 24 h. I uCi [';H]TdR per well was ad-
ded during the last 4 h of culture. Cells were harvested with an automated cell
harvester and thymidine incorporation was analyzed by liquid scintillation
counting.
I restriction. Mice were immunized with influenzaA, and after secondary stimula-
tion in vitro, spleen cells were assayed for cytotoxicity with histocompatible target
cells incubated with appropriate peptide or infected with influenza virus. Because
all the tumorcell lines used as target cellsexpress classIbutnot class II MHC mole-
cules, cytotoxicity must be class I restricted. As expected, infected target cells were
specifically lysed in each case. Furthermore, all five peptides also induced cytotox-
icity, although the percent specific "Cr release was greater for virally infected target
cells than for target cells in the presence ofpeptide (Fig. 2, a-e). This could be due
to the presence of additional class I epitopes on the virally expressed proteins or
to increaseddensityofantigen on the infected target cells. Nevertheless, all fivepep-
tides can clearly be recognized by T cells in a class I-restricted assay.
Structural homology between class I and II MHC molecules was observed in an
analysis ofthe human HLA-A2 class I and murine I-A' class II molecules (8). This
observation suggests that not only are class I and II molecules structurally similar
but also that the homology may be conserved across species. To test if individual
peptides can be immunogenic in both humans and rodents, two class I-restricted
peptides analyzed in human immune responses, influenza A nucleoprotein 335-49
(NP335-49, reference9) restrictedby HLA-B37 and influenzamatrix 55-73 (MA55-73,
reference 10) restricted by HLA-A2, were analyzed for murine class II responses
in CBA, BALB/c, and C57/B6 mice. Fig. 3 shows that both peptides generated a
positivemurine proliferative response, and in both cases the respondingTcells were
ofthe CD44 subset. For each peptide only one ofthe three haplotypes tested demon-
strated a proliferative T cell response demonstrating the specificity of the peptide
recognition (data from nonresponding haplotypes not shown). Thus, not only do
peptides defined in murine class I-restricted systems function in murine class II
systems, but also peptides defined in human class I-restricted systems function in
murine class II-restricted systems.
To determine the class II MHC restriction, H-2 recombinant mice (B10.A(4R),
B10.A(5R), B10.GD, andA.TL) were immunized with all seven peptides and lymph
node proliferation assayed (data not shown). Based on these results the MHC re-
Strain
APCs
Ak Ek
A/J 131 7
B10.A 38 0
Totals 169 7284
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FIGURE 2 .
￿
Cytotoxicity analyzed by 51Cr release using the same peptides as Fig . 1 . Peptides are
(a) NP50-63, (b) NP147-58, (c) NP365-80, (d) HA202-21, (e)HA523-45 . In each assay H-2-matched
target cells were infected with influenzaA, or incubated with the indicated peptide . Control pep-
tides consisted of residues 132-146 of myoglobin (Myo), 46-61 of lysozyme (Lys), and 73-88 of
X repressor cl (cí73-88) . Syngeneic target cells (O), plus peptide ("), plus influenzaA(A), and
plus control peptide (A), and allogeneictarget cells (EI), plus peptide (/), plus influenzaA(0),
and plus control peptide (") . Target cells were BW (a), P815 (b, d, and e), andEL-4 (c) . Specific
Cr release was calculated as : (experimental - spontaneous counts)/(total - spontaneous counts) .
Mouse strains were CBA (a), BALB/c (b, d, and e), and C57/B6 (c). Influenza A virus strains
were A/NT/60/68 (a, b, and c) and A/JAP/57 (d and e) .
strictions are shown in Table III . Some peptides, e.g ., NP50-63 and NP147-58, have
both a class I and II restriction functional in the same haplotype, H-2' and H-2d '
respectively. Otherpeptides, e.g., NP365-80 and HA523-45, demonstrate class I and
class II restriction only in different haplotypes (Db vs . Ak and Kd vs . A', respec-
tively) . One peptide, HA202-21, functions in threehaplotypes in aclass II-restrictedPERKINS ET AL .
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FIGURE 3 .
￿
Murine lymphnode proliferation analysis ofpeptides previously identified in human
class 1-restricted cytotoxic responses . Peptides are (a) NP335-49 and (b)MA55-73. Methodswere
thesame as in Fig. 1. No peptideandnomAb or C'(0), cI73-88 (peptide 73-88from X repressor
cI) with nomAb or C'(0), peptideandnomAb or C' (A), peptide plus anti-CD4 mAb(GK1.5)
plus C' (" ), peptide plus anti-CD8 mAb(AD4)plus C' (p), peptide plus antiThy-1 mAb (13.4)
plus C' (/), peptide plus anti-ARS mAb(45-112) plus C'(7), peptide plus C' without mAb(") .
Mice were CBA (a) and BALB/c (b) .
manner as well as class I Kd . Also shown are the crossreactivities between the
human class I and murine class II restrictions, HLA-B37 with I-Ak and HLA-A2
with I-Ad . It is striking that all seven peptides use an I-A class II MHC restriction .
However, based on thelimitednumber ofcurrently defined class I peptides available
to analyze, it is not clear ifthe incidence ofI-A restrictions is a coincidence or reflects
some unknown structural feature . Experimenta to investigate if class II-restricted
TABLE III
Class I and Class IIMHC Restrictions of Peptides
Peptides are amino acids 50-63 (NP50-63)117, 147-58 (NP147-58, reference
12), 335-49 (NP335-49, reference 9), and365-80 (NP365-80, reference 9) from
the nucleoprotein and 55-73 (MA55-73, reference 10) from the matrix protein
ofinfluenza A/NT/60/68, and 202-21 (HA202-21)139and523-45 (HA523-45)13
from the hemagglutinin ofinfluenza A/Jap/57 . In addition to the class II MHC
restrictions listed, additional I-Ed restrictions for NP147-58, M55-73, and
HA202-21 could not be excluded .
Peptide Class I Class II
Interclass Recognition
Nucleoprotein
NP50-63 Kk Ak
NP147-58 Kd Ad
NP365-80 Dd Ak
Hemagglutinin
HA202-21 Kd Ab,d,k
HA523-45 Kd Ak
Interspecies Recognition
Nucleoprotein
NP335-49 HLA-B37 Ak
Matrix
MA55-73 HLA-A2 Ad286
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peptides are in general immunogenic in class I responses are technically more difficult.
Using primary in vitro stimulation of naive spleen cells (24), no class I-restricted
cytotoxic responses were detectable against seven class II peptides examined in these
experiments . Interpretation ofthese results is not definitive becauseT cells induced
by primary in vitro stimulation frequently recognize different epitopes than T cells
induced with in vivo immunization (24) . However, the possibility that the require-
ments for class Ibinding of peptides may be more stringent than forclass II peptide
binding can not be excluded .
Discussion
Our data demonstrate that identical immunogenic peptides can stimulate CD8+
cytotoxic T cell responses in class I-restricted assays and CD4+ helper T cell re-
sponses in class II-restricted assays . Previous work by other groups has indicated
similarities between class I and IIMHC molecules (6-8), as well as betweenTCR
molecules from class I and II MHC-restricted T cells (1-5) . In conjunction with
our data that identical peptides demonstrate crossreactivities in both class I and 11-re-
stricted systems, all three molecules (TCR, MHC, and antigen) involved in T cell
recognition ofprocessed antigen in both class I and 11, as well as human and murine
restricted systems, are structurally andfunctionally similar. Previous reports of class
II-specific CD8+ T cells (although occurring at low frequency) are consistent with
the idea of similar recognition mechanisms in the class I and II systems (25) . This
is further supported by the isolation of a T cell clone that specifically recognizes
both a class I (Db) and a class II (I-E') molecule (26) . In the studies described here
it is striking that in at least one of the three strains tested (H-2b,d,k) class II re-
sponses were identified against all seven previously defined class I peptides .
The data also indicate that although mechanisms ofT cell recognition of antigen
are similar in both systems, the immune response to a specific immunization produces
either a class I or a class II response to a particular peptide even in mouse strains
potentially capable of responding via both types ofMHC restriction . For example,
CBA mice could potentially respond to NP50-63 via both class I Kk and class II
A' . However, depending upon the mode of immunization either a class I (after im-
munization with live virus) or class II (after immunization with peptide plus adju-
vant) response predominates (Figs . 1 a and 2 a) . One hypothesis consistent with
this observation is that class I MHC molecules have more stringent requirements
forpeptide binding ; therefore, class I-restricted peptides area subset of all immuno-
genic peptides . Another, not mutually exclusive hypothesis is that processed antigens
from intracytoplasmic proteins associate with class I molecules, and extracellular
antigens from soluble proteins associate with class II molecules via two separate
pathways of processing (27-28) . Further support for this hypothesis is based on re-
cent experiments demonstrating that APCs plus soluble ovalbumin induce class II
T cell responses ; whereas, ifthe protein is introduced intracytoplasmically by hypo-
tonic vesicles, then class I responses are induced (24) . Experiments are currently
underway to test this hypothesis using classI and II-restricted T cells that recognize
the identical peptide . In conclusion, themechanism bywhichTcells recognize pep-
tides or processed antigen in the context ofMHC molecules appears to have been
evolutionarily conserved by the class I and class IIMHC systems and across species
by humans and mice.PERKINS ET AL.
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Summary
Previous data from many groups show that both class I and class II-restricted
T cells recognize short synthetic peptides in the context of their respective MHC
molecules (9-18). all of the peptides described to date are restricted to only a single
class of MHC molecules; however, structural homology between the class I and II
MHC molecules and the use of similar TCRs by class I and II-restricted T cells
suggest that antigen recognition mechanisms are similar in both systems. To directly
compare antigen recognition in the two systems, we analyzed peptides for the ability
to function in both a class I and II-restricted system and found that seven of seven
individual peptides tested stimulate both class I and II-restricted T cell responses.
In addition, two of the peptides can function in different species stimulating both
human class I and murine class II T cell responses. Thus, the process ofT cell recog-
nition of antigen in the context of MHC molecules was highly conserved in evolu-
tion not only between the class I and class II MHC systems, but also between the
murine and human species.
We would like to thank Dr. Herman Eisen, Dr. David Raulet, and Dr. Thomas Briner for
critical reading of the manuscript and helpful discussions.
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